Literature DB >> 18830063

High levels of antibodies to Plasmodium falciparum liver stage antigen-1 in naturally infected individuals in Myanmar.

Hyeong-Woo Lee1, Sung-Ung Moon, Yeon-Joo Kim, Shin-Hyeong Cho, Khin Lin, Byoung-Kuk Na, Tong-Soo Kim.   

Abstract

Plasmodium falciparum liver stage antigen-1 (PfLSA-1) is one of the few antigens expressed exclusively in liver stage parasites. In this study, we evaluated the antibody responses against recombinant PfLSA-1 in naturally infected individuals in Myanmar. High levels of antibody responses (70.7%) were detected in 82 serum samples from 116 infected individuals, and IgG responses to PfLSA-1 principally composed of responses of IgG1 and IgG3 subclasses. These results show that PfLSA-1 elicits effective antibody responses in individuals infected with P. falciparum, and thus it could be not only an attractive candidate protein for vaccine development, but also a useful antigen for serodiagnosis of the infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830063      PMCID: PMC2553336          DOI: 10.3347/kjp.2008.46.3.195

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  19 in total

1.  Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine.

Authors:  J D Kurtis; M R Hollingdale; A J Luty; D E Lanar; U Krzych; P E Duffy
Journal:  Trends Parasitol       Date:  2001-05

2.  Non-CS pre-erythrocytic protective antigens.

Authors:  M R Hollingdale; M Aikawa; C T Atkinson; W R Ballou; G X Chen; J Li; J F Meis; B Sina; C Wright; J D Zhu
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

3.  The complexity of protective immunity against liver-stage malaria.

Authors:  D L Doolan; S L Hoffman
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

4.  Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India.

Authors:  S K Joshi; A Bharadwaj; S Chatterjee; V S Chauhan
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

5.  Lymphocyte proliferation and antibody responses to Plasmodium falciparum liver-stage antigen-1 in a highland area of Kenya with seasonal variation in malaria transmission.

Authors:  Chandy C John; John H Ouma; Peter O Sumba; Michael R Hollingdale; James W Kazura; Chris L King
Journal:  Am J Trop Med Hyg       Date:  2002-04       Impact factor: 2.345

Review 6.  Immunity to asexual blood stage malaria and vaccine approaches.

Authors:  Jiraprapa Wipasa; Salenna Elliott; Huji Xu; Michael F Good
Journal:  Immunol Cell Biol       Date:  2002-10       Impact factor: 5.126

7.  A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.

Authors:  C Guerin-Marchand; P Druilhe; B Galey; A Londono; J Patarapotikul; R L Beaudoin; C Dubeaux; A Tartar; O Mercereau-Puijalon; G Langsley
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

8.  Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya.

Authors:  Chandy C John; Joseph S Zickafoose; P Odada Sumba; Christopher L King; James W Kazura
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 9.  Immunity to liver stage malaria: considerations for vaccine design.

Authors:  Andrew W Taylor-Robinson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti-P. falciparum antibodies in different sera.

Authors:  M Wahlgren; K Berzins; P Perlmann; M Persson
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

View more
  2 in total

1.  High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection.

Authors:  Thomas Jaenisch; Kirsten Heiss; Nico Fischer; Carolin Geiger; F Ralf Bischoff; Gerhard Moldenhauer; Leszek Rychlewski; Ali Sié; Boubacar Coulibaly; Peter H Seeberger; Lucjan S Wyrwicz; Frank Breitling; Felix F Loeffler
Journal:  Mol Cell Proteomics       Date:  2019-01-10       Impact factor: 5.911

2.  Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar.

Authors:  Tong-Soo Kim; Hyung-Hwan Kim; Jung-Yeon Kim; Yoon Kong; Byoung-Kuk Na; Khin Lin; Sung-Ung Moon; Yeon-Joo Kim; Myoung-Hee Kwon; Youngjoo Sohn; Hyuck Kim; Hyeong-Woo Lee
Journal:  Malar J       Date:  2011-08-06       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.